PROCHLORPERAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prochlorperazine, and what generic alternatives are available?
Prochlorperazine is a drug marketed by Alpharma Us Pharms, Baxter Hlthcare, Able, Cosette, Watson Labs, Morton Grove, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Wyeth Ayerst, Ajanta Pharma Ltd, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva Pharms, and Zydus Lifesciences. and is included in forty-four NDAs.
The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine
A generic version of PROCHLORPERAZINE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCHLORPERAZINE?
- What are the global sales for PROCHLORPERAZINE?
- What is Average Wholesale Price for PROCHLORPERAZINE?
Summary for PROCHLORPERAZINE
![PROCHLORPERAZINE drug patent expirations Drug patent expirations by year for PROCHLORPERAZINE](/p/graph/s/t/PROCHLORPERAZINE-patent-expirations.png)
![Drug Prices for PROCHLORPERAZINE](/p/graph/drug-price/PROCHLORPERAZINE.png)
See drug prices for PROCHLORPERAZINE
![Drug Sales Revenue Trends for PROCHLORPERAZINE](/p/graph/drug-sales-revenues/PROCHLORPERAZINE.png)
Recent Clinical Trials for PROCHLORPERAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assertio Holdings, Inc | Phase 2 |
Washington University School of Medicine | Phase 2 |
University of Calgary | Phase 3 |
Pharmacology for PROCHLORPERAZINE
Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE
Anatomical Therapeutic Chemical (ATC) Classes for PROCHLORPERAZINE
US Patents and Regulatory Information for PROCHLORPERAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 040101-003 | Jul 19, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Morton Grove | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | SYRUP;ORAL | 088597-001 | Oct 25, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Sub Teva Pharms | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 040162-001 | Jan 20, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Duramed Pharms Barr | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 089485-001 | Jan 20, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |